What Clinical Trials Show In clinical trials of FDA-approved semaglutide (Wegovy) and tirzepatide (Zepbound): Semaglutide (Wegovy): In large clinical trials of FDA-approved products, average weight loss was meaningful over roughly 68 weeks when paired with lifestyle support (reduced-calorie diet and increased physical activity)
Rapid response to prevent and treat B12/Co deficiency
When they can easily track protein and fluid intake on their Dashboard, along with medication dosing, symptoms, and weight trends, it becomes much easier to communicate with their healthcare team and feel confident they are on track for long-term success," said Sue Heikkinen, MS, RDN, CDCES, BC-ADM, ACE-PT, Lead Dietitian and Clinical Reviewer at MyNetDiary
Association of Official Analytical Chemists